Profit

In a recent legal battle, Johnson & Johnson and Bristol Myers Squibb faced a setback in their challenge to the Biden administration’s Medicare drug price negotiations. A federal judge in New Jersey rejected their legal arguments, ruling that the program is constitutional. The decision is a significant win for the Biden administration in its efforts
0 Comments
The first stock favored by the Street’s top pros is Netflix (NFLX). The streaming giant recently reported better-than-expected results for the first quarter of 2024. Despite the positive earnings report, investors were disappointed with the company’s decision to stop reporting quarterly subscriber numbers. Netflix emphasized a shift in focus towards revenue and operating margin metrics.
0 Comments
The American economy is facing significant challenges as the Federal Reserve continues to raise interest rates, leading to fears of slower growth and inflation. However, Jose Rasco, chief investment officer of the Americas at HSBC’s wealth division, believes that certain key drivers will help sustain economic growth. One such driver is technology deflation. While advancements
0 Comments
Meta Platforms, the parent company of Facebook, faced a significant drop of more than 14% following the release of lighter-than-expected second-quarter revenue guidance. Despite this setback, the company managed to exceed analysts’ estimates for both earnings and revenue in the first quarter. On the other hand, Honeywell, an industrial stock, saw a 2.2% rise in
0 Comments
UnitedHealth Group (UNH) saw a significant 16% increase in its stock following a strong earnings report, despite facing challenges such as the recent cyberattack on its subsidiary, Change Healthcare. However, recent market trends have begun to reveal cracks in UNH’s once robust rally. Two key technical indicators suggest a bearish bias on UNH: the Relative
0 Comments